COVID-19 Is Forcing Us to Rethink Clinical Trials for Cancer Treatments
COVID-19 Is Forcing Us to Rethink Clinical Trials for Cancer Treatments Pat Basu In 2018, the American Cancer Society released an alarming report noting that 20 percent of clinical trials fail because of insufficient patient enrollment and that 56 percent of patients seeking care will not have a clinical trial in their immediate area and…